Community Foundation honors Pleasanton Weekly | December 9, 2011 | Pleasanton Weekly | |

Pleasanton Weekly

News - December 9, 2011

Community Foundation honors Pleasanton Weekly

Named 'Community Champion' for Holiday Fund contributions

by Jeb Bing

The Tri-Valley Community Foundation presented the Pleasanton Weekly with its "Community Champion" award Wednesday for the newspaper's annual Holiday Fund program that raises funds for local nonprofit organizations.

The Weekly was one of five "Champions" recognized by the Foundation at an awards ceremony at the Palm Event Center in Pleasanton.

In making the award, David Rice, president and chief executive of the foundation, said the Pleasanton Weekly's annual Holiday Fund "has raised awareness of the human needs in the Tri-Valley and has raised more than $1 million to support local charities since its inception nine years ago."

The award was accepted by Gina Channell-Allen, president and publisher of the Pleasanton Weekly, and Jeb Bing, the newspaper's editor.

Others who were recognized at the foundation's first annual Community Champions program were:

* Bob Tucknott, a local electrical contractor who recently completed his 1,000th "Angel Flight" to transport seriously ill patients to distant hospitals.

* Bruce Campbell, a "master gardener" who created the "Garden of Grace," a community garden in Livermore that grows huge quantities of food to feed low-income families through organizations such as Open Heart Kitchen and the Asbury United Methodist Church.

* 1st United Services Credit Union, the original credit union serving Alameda County employees, which has a long track record of charitable giving in support of education and health care, and that has been a huge supporter of local charities since opening its office in Pleasanton.

* Dana Dornsife, who founded the Lazarex Cancer Foundation, a nationwide charity headquartered in Danville. The Lazarex Foundation provides financial assistance to terminally ill cancer patients who cannot afford the cost of room or board or the cost to travel long distances to participate in clinical trials of experimental cancer treatments.


There are no comments yet for this post